-
Je něco špatně v tomto záznamu ?
MMP-12, Secreted by Pro-Inflammatory Macrophages, Targets Endoglin in Human Macrophages and Endothelial Cells
M. Aristorena, E. Gallardo-Vara, M. Vicen, M. de Las Casas-Engel, L. Ojeda-Fernandez, C. Nieto, FJ. Blanco, AC. Valbuena-Diez, LM. Botella, P. Nachtigal, AL. Corbi, M. Colmenares, C. Bernabeu,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
SAF2013-43421-R to CB; SAF2017-83785-R and SAF2014-23801 to ALC
Ministerio de Ciencia e Innovación
201920E022 to CB
Consejo Superior de Investigaciones Científicas
ISCIII-CB06/07/0038 to CB
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
SVV-260414 to PN
Czech Republic Specific University Research
NLK
Directory of Open Access Journals
od 2000
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
31242676
DOI
10.3390/ijms20123107
Knihovny.cz E-zdroje
- MeSH
- biologické modely MeSH
- endoglin genetika metabolismus MeSH
- endoteliální buňky metabolismus MeSH
- exprese genu MeSH
- faktor stimulující granulocyto-makrofágové kolonie metabolismus MeSH
- faktor stimulující kolonie makrofágů metabolismus MeSH
- kultivované buňky MeSH
- lidé MeSH
- makrofágy imunologie metabolismus MeSH
- matrixová metaloproteinasa 12 metabolismus MeSH
- mediátory zánětu metabolismus MeSH
- modely nemocí na zvířatech MeSH
- myši MeSH
- náchylnost k nemoci MeSH
- zánět etiologie metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Upon inflammation, monocyte-derived macrophages (MΦ) infiltrate blood vessels to regulate several processes involved in vascular pathophysiology. However, little is known about the mediators involved. Macrophage polarization is crucial for a fast and efficient initial response (GM-MΦ) and a good resolution (M-MΦ) of the inflammatory process. The functional activity of polarized MΦ is exerted mainly through their secretome, which can target other cell types, including endothelial cells. Endoglin (CD105) is a cell surface receptor expressed by endothelial cells and MΦ that is markedly upregulated in inflammation and critically involved in angiogenesis. In addition, a soluble form of endoglin with anti-angiogenic activity has been described in inflammation-associated pathologies. The aim of this work was to identify components of the MΦ secretome involved in the shedding of soluble endoglin. We find that the GM-MΦ secretome contains metalloprotease 12 (MMP-12), a GM-MΦ specific marker that may account for the anti-angiogenic activity of the GM-MΦ secretome. Cell surface endoglin is present in both GM-MΦ and M-MΦ, but soluble endoglin is only detected in GM-MΦ culture supernatants. Moreover, MMP-12 is responsible for the shedding of soluble endoglin in vitro and in vivo by targeting membrane-bound endoglin in both MΦ and endothelial cells. These data demonstrate a direct correlation between GM-MΦ polarization, MMP-12, and soluble endoglin expression and function. By targeting endothelial cells, MMP-12 may represent a novel mediator involved in vascular homeostasis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044721
- 003
- CZ-PrNML
- 005
- 20200113081227.0
- 007
- ta
- 008
- 200109s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms20123107 $2 doi
- 035 __
- $a (PubMed)31242676
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Aristorena, Mikel $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. m.aristorena@ucl.ac.uk. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain. m.aristorena@ucl.ac.uk.
- 245 10
- $a MMP-12, Secreted by Pro-Inflammatory Macrophages, Targets Endoglin in Human Macrophages and Endothelial Cells / $c M. Aristorena, E. Gallardo-Vara, M. Vicen, M. de Las Casas-Engel, L. Ojeda-Fernandez, C. Nieto, FJ. Blanco, AC. Valbuena-Diez, LM. Botella, P. Nachtigal, AL. Corbi, M. Colmenares, C. Bernabeu,
- 520 9_
- $a Upon inflammation, monocyte-derived macrophages (MΦ) infiltrate blood vessels to regulate several processes involved in vascular pathophysiology. However, little is known about the mediators involved. Macrophage polarization is crucial for a fast and efficient initial response (GM-MΦ) and a good resolution (M-MΦ) of the inflammatory process. The functional activity of polarized MΦ is exerted mainly through their secretome, which can target other cell types, including endothelial cells. Endoglin (CD105) is a cell surface receptor expressed by endothelial cells and MΦ that is markedly upregulated in inflammation and critically involved in angiogenesis. In addition, a soluble form of endoglin with anti-angiogenic activity has been described in inflammation-associated pathologies. The aim of this work was to identify components of the MΦ secretome involved in the shedding of soluble endoglin. We find that the GM-MΦ secretome contains metalloprotease 12 (MMP-12), a GM-MΦ specific marker that may account for the anti-angiogenic activity of the GM-MΦ secretome. Cell surface endoglin is present in both GM-MΦ and M-MΦ, but soluble endoglin is only detected in GM-MΦ culture supernatants. Moreover, MMP-12 is responsible for the shedding of soluble endoglin in vitro and in vivo by targeting membrane-bound endoglin in both MΦ and endothelial cells. These data demonstrate a direct correlation between GM-MΦ polarization, MMP-12, and soluble endoglin expression and function. By targeting endothelial cells, MMP-12 may represent a novel mediator involved in vascular homeostasis.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a endoglin $x genetika $x metabolismus $7 D000071063
- 650 _2
- $a endoteliální buňky $x metabolismus $7 D042783
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a faktor stimulující granulocyto-makrofágové kolonie $x metabolismus $7 D016178
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x etiologie $x metabolismus $7 D007249
- 650 _2
- $a mediátory zánětu $x metabolismus $7 D018836
- 650 _2
- $a faktor stimulující kolonie makrofágů $x metabolismus $7 D016173
- 650 _2
- $a makrofágy $x imunologie $x metabolismus $7 D008264
- 650 _2
- $a matrixová metaloproteinasa 12 $x metabolismus $7 D053508
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a biologické modely $7 D008954
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gallardo-Vara, Eunate $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. eunate.gallardo@yale.edu. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain. eunate.gallardo@yale.edu.
- 700 1_
- $a Vicen, Matej $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, 500 05 Hradec Kralove, Czech Republic. matej.vicen@gmail.com.
- 700 1_
- $a de Las Casas-Engel, Mateo $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. mcasas@cib.csic.es.
- 700 1_
- $a Ojeda-Fernandez, Luisa $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. mluisa.ojeda@gmail.com. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain. mluisa.ojeda@gmail.com.
- 700 1_
- $a Nieto, Concepción $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. cnieto@cib.csic.es.
- 700 1_
- $a Blanco, Francisco J $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. fjblanco@ugr.es. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain. fjblanco@ugr.es.
- 700 1_
- $a Valbuena-Diez, Ana C $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. ac22vd@hotmail.com. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain. ac22vd@hotmail.com.
- 700 1_
- $a Botella, Luisa M $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. cibluisa@cib.csic.es. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain. cibluisa@cib.csic.es.
- 700 1_
- $a Nachtigal, Petr $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, 500 05 Hradec Kralove, Czech Republic. nachtigal@faf.cuni.cz.
- 700 1_
- $a Corbi, Angel L $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. acorbi@cib.csic.es.
- 700 1_
- $a Colmenares, María $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. maria.colmenares@cib.csic.es.
- 700 1_
- $a Bernabeu, Carmelo $u Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain. bernabeu.c@cib.csic.es. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain. bernabeu.c@cib.csic.es.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 12 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31242676 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113081559 $b ABA008
- 999 __
- $a ok $b bmc $g 1482990 $s 1083394
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 12 $e 20190625 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a SAF2013-43421-R to CB; SAF2017-83785-R and SAF2014-23801 to ALC $p Ministerio de Ciencia e Innovación
- GRA __
- $a 201920E022 to CB $p Consejo Superior de Investigaciones Científicas
- GRA __
- $a ISCIII-CB06/07/0038 to CB $p Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
- GRA __
- $a SVV-260414 to PN $p Czech Republic Specific University Research
- LZP __
- $a Pubmed-20200109